Kadimastem (XTAE:KDST) Accounts Payable & Accrued Expense : ₪2.75 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Accounts Payable & Accrued Expense?

Kadimastem's quarterly accounts payable & accrued expense declined from Dec. 2022 (₪4.96 Mil) to Jun. 2023 (₪2.98 Mil) and declined from Jun. 2023 (₪2.98 Mil) to Dec. 2023 (₪2.75 Mil).

Kadimastem's annual accounts payable & accrued expense declined from Dec. 2021 (₪5.21 Mil) to Dec. 2022 (₪4.96 Mil) and declined from Dec. 2022 (₪4.96 Mil) to Dec. 2023 (₪2.75 Mil).

Kadimastem Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kadimastem's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Accounts Payable & Accrued Expense Chart

Kadimastem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6.70

3.83

5.21

4.96

2.75

Kadimastem Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial														5.21	5.18	4.96	2.98	2.75

Kadimastem Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kadimastem (XTAE:KDST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

KMSTF:USA

Address

Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR

Website

http://www.kadimastem.com

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines